Literature DB >> 21360486

Personalized medicine in rheumatoid arthritis: miles to go before we sleep.

Robert M Plenge, S Louis Bridges.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21360486      PMCID： PMC4036067          DOI： 10.1002/art.30126

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  18 in total

1.  Integrating pathway analysis and genetics of gene expression for genome-wide association studies.

Authors:  Hua Zhong; Xia Yang; Lee M Kaplan; Cliona Molony; Eric E Schadt
Journal:  Am J Hum Genet       Date:  2010-03-25       Impact factor: 11.025

2.  ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

Authors:  Jacques Fellay; Alexander J Thompson; Dongliang Ge; Curtis E Gumbs; Thomas J Urban; Kevin V Shianna; Latasha D Little; Ping Qiu; Arthur H Bertelsen; Mark Watson; Amelia Warner; Andrew J Muir; Clifford Brass; Janice Albrecht; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2010-02-21       Impact factor: 49.962

Review 3.  A HapMap harvest of insights into the genetics of common disease.

Authors:  Teri A Manolio; Lisa D Brooks; Francis S Collins
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

4.  Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families.

Authors:  Damini Jawaheer; Michael F Seldin; Christopher I Amos; Wei V Chen; Russell Shigeta; Carol Etzel; Aarti Damle; Xiangli Xiao; Dong Chen; Raymond F Lum; Joanita Monteiro; Marlene Kern; Lindsey A Criswell; Salvatore Albani; J Lee Nelson; Daniel O Clegg; Richard Pope; Harry W Schroeder; S Louis Bridges; David S Pisetsky; Ryk Ward; Daniel L Kastner; Ronald L Wilder; Theodore Pincus; Leigh F Callahan; Donald Flemming; Mark H Wener; Peter K Gregersen
Journal:  Arthritis Rheum       Date:  2003-04

5.  A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases.

Authors:  D Jawaheer; M F Seldin; C I Amos; W V Chen; R Shigeta; J Monteiro; M Kern; L A Criswell; S Albani; J L Nelson; D O Clegg; R Pope; H W Schroeder ; S L Bridges ; D S Pisetsky; R Ward; D L Kastner; R L Wilder; T Pincus; L F Callahan; D Flemming; M H Wener; P K Gregersen
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

6.  Associations between tumor necrosis factor-alpha (TNF-alpha) -308 and -238 G/A polymorphisms and shared epitope status and responsiveness to TNF-alpha blockers in rheumatoid arthritis: a metaanalysis update.

Authors:  Young Ho Lee; Jong Dae Ji; Sang-Cheol Bae; Gwan Gyu Song
Journal:  J Rheumatol       Date:  2010-03-01       Impact factor: 4.666

Review 7.  Genome-wide association studies in pharmacogenomics: successes and lessons.

Authors:  Alison A Motsinger-Reif; Eric Jorgenson; Mary V Relling; Deanna L Kroetz; Richard Weinshilboum; Nancy J Cox; Dan M Roden
Journal:  Pharmacogenet Genomics       Date:  2013-08       Impact factor: 2.089

8.  Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis.

Authors:  Chunyu Liu; Franak Batliwalla; Wentian Li; Annette Lee; Ronenn Roubenoff; Evan Beckman; Houman Khalili; Aarti Damle; Marlena Kern; Richard Furie; Josée Dupuis; Robert M Plenge; Marieke J H Coenen; Timothy W Behrens; John P Carulli; Peter K Gregersen
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

Review 9.  TNF-alpha-308 G/A polymorphism and responsiveness to TNF-alpha blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  D D O'Rielly; N M Roslin; J Beyene; A Pope; P Rahman
Journal:  Pharmacogenomics J       Date:  2009-04-14       Impact factor: 3.550

10.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.

Authors:  Shaun M Purcell; Naomi R Wray; Jennifer L Stone; Peter M Visscher; Michael C O'Donovan; Patrick F Sullivan; Pamela Sklar
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962
View more
  3 in total

1.  Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.

Authors:  Jose Manuel Sánchez-Maldonado; Rafael Cáliz; Miguel Ángel López-Nevot; Antonio José Cabrera-Serrano; Ana Moñiz-Díez; Helena Canhão; Rob Ter Horst; Luca Quartuccio; Signe B Sorensen; Bente Glintborg; Merete L Hetland; Ileana Filipescu; Eva Pérez-Pampin; Pablo Conesa-Zamora; Jerzy Swierkot; Alfons A den Broeder; Salvatore De Vita; Eva Rabing Brix Petersen; Yang Li; Miguel A Ferrer; Alejandro Escudero; Mihai G Netea; Marieke J H Coenen; Vibeke Andersen; João E Fonseca; Manuel Jurado; Katarzyna Bogunia-Kubik; Eduardo Collantes; Juan Sainz
Journal:  Front Immunol       Date:  2021-10-27       Impact factor: 7.561

2.  Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?

Authors:  Karina I Halilova; Elizabeth E Brown; Sarah L Morgan; S Louis Bridges; Min-Ho Hwang; Donna K Arnett; Maria I Danila
Journal:  Int J Rheumatol       Date:  2012-07-09

3.  Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis.

Authors:  Jonathan Massey; Darren Plant; Kimme Hyrich; Ann W Morgan; Anthony G Wilson; Athina Spiliopoulou; Marco Colombo; Paul McKeigue; John Isaacs; Heather Cordell; Costantino Pitzalis; Anne Barton
Journal:  Pharmacogenomics J       Date:  2018-08-31       Impact factor: 3.550
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.